The antimicrobial activity of ZnO nanoparticles against Vibrio cholerae: Variation in response depends on biotype

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 6, 2016, Pages 1499-1509

  Sarwar, Shamila ^a   Chakraborti, Soumyananda ^a,c   Bera, Supriyo ^a   Sheikh, Irshad Ali ^b   Hoque, Kazi Mirajul ^b   Chakrabarti, Pinak ^a  

^a BOSE INSTITUTE   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Antibacterial activity; Biofilms; Membrane fluidity; Reactive oxygen species; Vibrio cholerae; ZnO nanoparticle

Indexed keywords

BIOFILMS; DISEASES; FLUIDITY; METAL NANOPARTICLES; MICROORGANISMS; NANOPARTICLES;

ANTI-BACTERIAL ACTIVITY; MEMBRANE FLUIDITY; REACTIVE OXYGEN SPECIES; VIBRIO CHOLERAE; ZNO NANOPARTICLES;

ZINC OXIDE;

BACTERIAL DNA; KANAMYCIN; REACTIVE OXYGEN METABOLITE; ZINC OXIDE NANOPARTICLE; ANTIINFECTIVE AGENT; NANOPARTICLE; ZINC OXIDE;

ACCUMULATION INDEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL MEMBRANE; BACTERIOPLANKTON; BIOFILM; BIOTYPE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE FLUIDITY; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOARCHITECTURE; DNA DAMAGE; DNA DEGRADATION; DNA FRAGMENTATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RESPONSE; DRUG STRUCTURE; FLUORESCENCE POLARIZATION; INTESTINE LOOP; MEMBRANE DAMAGE; MEMBRANE FLUIDITY; MOUSE; NONHUMAN; PARTICLE SIZE; SINGLE DRUG DOSE; VIBRIO CHOLERAE; ANIMAL; CHOLERA; DRUG EFFECTS;

ANIMALS; ANTI-INFECTIVE AGENTS; CHOLERA; NANOPARTICLES; VIBRIO CHOLERAE; ZINC OXIDE;

EID: 84964950524     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2016.02.006     Document Type: Article

References (59)

1. Gugnani H.C. Some emerging food and water borne pathogens. J Commun Dis 1999, 31:65-72.
2. Charles R.C., Ryan E.T. Cholera in the 21st century. Curr Opin Infect Dis 2011, 24:472-477.
3. Faruque S.M., Chowdhury N., Kamruzzaman M., Dziejman M., Rahman M.H., Sack D.A., et al. Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area. Proc Natl Acad Sci U S A 2004, 101:2123-2128.
4. Andersson D.I., Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 2014, 12:465-478.
5. Mala E., Oberoi A., Alexander V.S. Vibrio isolates from cases of acute diarrhea and their antimicrobial susceptibility pattern in a tertiary care hospital 2014, 3:3. [2014].
6. Chatterjee T., Chatterjee B.K., Majumdar D., Chakrabarti P. Antibacterial effect of silver nanoparticles and the modeling of bacterial growth kinetics using a modified Gompertz model. Biochim Biophys Acta 1850, 2015:299-306.
7. Zhao Y., Tian Y., Cui Y., Liu W., Ma W., Jiang X. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J Am Chem Soc 2010, 132:12349-12356.
8. Azam A., Ahmed A.S., Oves M., Khan M.S., Habib S.S., Memic A. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int J Nanomedicine 2012, 7:6003-6009.
9. Ashkarran A.A., Ghavami M., Aghaverdi H., Stroeve P., Mahmoudi M. Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles. Chem Res Toxicol 2012, 25(6):1231-1242.
10. Jayakumar R., Menon D., Manzoor K., Nair S.V., Tamura H. Biomedical applications of chitin and chitosan based nanomaterials-a short review. Carbohydr Polym 2010, 82:227-232.
11. Hajipour M.J., Fromm K.M., Ashkarran A.A., Jimenez de Aberasturi D., de Larramendi I.R., Rojo T., et al. Antibacterial properties of nanoparticles. Trends Biotechnol 2012, 30:499-511.
12. Valencia P.M., Farokhzad O.C., Karnik R., Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol 2012, 7:623-629.
13. Gao J., Xu B. Applications of nanomaterials inside cells. Nano Today 2009, 4:37-51.
14. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
15. Sinha R., Karan R., Sinha A., Khare S.K. Interaction and nanotoxic effect of ZnO and Ag nanoparticles on mesophilic and halophilic bacterial cells. Bioresour Technol 2011, 102:1516-1520.
16. Jiang W., Mashayekhi H., Xing B. Bacterial toxicity comparison between nano- and micro-scaled oxide particles. Environ Pollut 2009, 157:1619-1625.
17. Stoimenov P.K., Klinger R.L., Marchin G.L., Klabunde K.J. Metal oxide nanoparticles as bactericidal agents. Langmuir 2002, 18:6679-6686.
18. Joshi P., Chakraborti S., Chakrabarti P., Haranath D., Shanker V., Ansari Z.A., et al. Role of surface adsorbed anionic species in antibacterial activity of ZnO quantum dots against Escherichia coli. J Nanosci Nanotechnol 2009, 9:6427-6433.
19. Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Cogliano V. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol 2006, 7:295-296.
20. Rasmussen J.W., Martinez E., Louka P., Wingett D.G. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010, 7:1063-1077.
21. Espitia P., Soares N.d., Coimbra J.d., de Andrade N., Cruz R., Medeiros E. Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications. Food Bioprocess Technol 2012, 5:1447-1464.
22. Li M., Zhu L., Lin D. Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci Technol 2011, 45:1977-1983.
23. Krishnaraj C., Jagan E.G., Rajasekar S., Selvakumar P., Kalaichelvan P.T., Mohan N. Synthesis of silver nanoparticles using Acalypha indica leaf extracts and its antibacterial activity against water borne pathogens. Colloids Surf B: Biointerfaces 2010, 76:50-56.
24. Nanda A., Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine 2009, 5:452-456.
25. Salem W., Leitner D.R., Zingl F.G., Schratter G., Prassl R., Goessler W., et al. Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli. Int J Med Microbiol 2015, 305:85-95.
26. Chakraborti S., Bhattacharya S., Chowdhury R., Chakrabarti P. The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles. PLoS One 2013, 8.
27. Chakraborti S., Mandal A.K., Sarwar S., Singh P., Chakraborty R., Chakrabarti P. Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island. Colloids Surf B: Biointerfaces 2014, 121:44-53.
28. Chatterjee T., Chakraborti S., Joshi P., Singh S.P., Gupta V., Chakrabarti P. The effect of zinc oxide nanoparticles on the structure of the periplasmic domain of the Vibrio cholerae ToxR protein. FEBS J 2010, 277:4184-4194.
29. Casey J.T., O'Cleirigh C., Walsh P.K., O'Shea D.G. Development of a robust microtiter plate-based assay method for assessment of bioactivity. J Microbiol Methods 2004, 58:327-334.
30. Kumar A., Pandey A.K., Singh S.S., Shanker R., Dhawan A. A flow cytometric method to assess nanoparticle uptake in bacteria. Cytometry A 2011, 79:707-712.
31. Sen I.K., Mandal A.K., Chakraborti S., Dey B., Chakraborty R., Islam S.S. Green synthesis of silver nanoparticles using glucan from mushroom and study of antibacterial activity. Int J Biol Macromol 2013, 62:439-449.
32. Cui Y., Zhao Y., Tian Y., Zhang W., Lu X., Jiang X. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials 2012, 33:2327-2333.
33. Rose W.E., Schulz L.T., Andes D., Striker R., Berti A.D., Hutson P.R., et al. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Antimicrob Agents Chemother 2012, 56:5296-5302.
34. Wu M., Maier E., Benz R., Hancock R.E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 1999, 38:7235-7242.
35. Letellier L., Shechter E. Cyanine dye as monitor of membrane potentials in Escherichia coli cells and membrane vesicles. Eur J Biochem 1979, 102:441-447.
36. O'Toole G.A. Microtiter dish biofilm formation assay. J Vis Exp 2011, 47:2437.
37. - secretion via modulation of apical KCNN4c channels in diarrhea. J Biol Chem 2013, 288:20404-20415.
38. Chakraborti S., Chatterjee T., Joshi P., Poddar A., Bhattacharya B., Singh S.P., et al. Structure and activity of lysozyme on binding to ZnO nanoparticles. Langmuir 2010, 26(5):3506-3513.
39. Joshi P., Chakraborti S., Chakrabarti P., Singh S.P., Ansari Z.A., Husain M., et al. ZnO nanoparticles as an antibacterial agent against E. coli. Sci Adv Mater 2012, 4:173-178.
40. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-182.
41. Bian S.W., Mudunkotuwa I.A., Rupasinghe T., Grassian V.H. Aggregation and dissolution of 4 nm ZnO nanoparticles in aqueous environments: influence of pH, ionic strength, size, and adsorption of humic acid. Langmuir 2011, 27:6059-6068.
42. Sims P.J., Waggoner A.S., Wang C.H., Hoffman J.F. Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry 1974, 13:3315-3330.
43. Weber G. Theory of fluorescence depolarization by anisotropic Brownian rotations. discontinuous distribution approach. J Chem Phys 1971, 55:2399-2407.
44. Shinitzky M., Inbar M. Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J Mol Biol 1974, 85:603-615.
45. Shinitzky M., Inbar M. Microviscosity parameters and protein mobility in biological membranes. Biochim Biophys Acta 1976, 433:133-149.
46. Kapuscinski J. DAPI: a DNA-specific fluorescent probe. Biotech Histochem 1995, 70:220-233.
47. Raghupathi K.R., Koodali R.T., Manna A.C. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 2011, 27:4020-4028.
48. Apel K., Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 2004, 55:373-399.
49. Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 2010, 594:57-72.
50. Shahverdi A.R., Fakhimi A., Shahverdi H.R., Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 2007, 3:168-171.
51. Ping Li J.L., Wu Changzhu, Wu Qingsheng, Li Jian Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005, 16:1912.
52. Teschler J.K., Zamorano-Sanchez D., Utada A.S., Warner C.J.A., Wong G.C.L., Linington R.G., et al. Living in the matrix: assembly and control of Vibrio cholerae biofilms. Nat Rev Microbiol 2015, 13:255-268.
53. Mwansa J.C., Mwaba J., Lukwesa C., Bhuiyan N.A., Ansaruzzaman M., Ramamurthy T., et al. Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol Infect 2007, 135:847-853.
54. H.A., Dechsakulthorn F., Bakand S., Joeng L., Winder C. In vitro cytotoxicity assessment of selected nanoparticles using human skin fibroblasts. AATEX 2007, 14:397-400.
55. Dziejman M., Balon E., Boyd D., Fraser C.M., Heidelberg J.F., Mekalanos J.J. Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci 2002, 99:1556-1561.
56. Stewart P.S. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002, 292:107-113.
57. Hoque K.M., Rajendran V.M., Binder H.J. Zinc inhibits cAMP-stimulated Cl secretion via basolateral K-channel blockade in rat ileum. Am J Physiol Gastrointest Liver Physiol 2005, 288:G956-G963.
58. Wadhwa N., Natchu U.C., Sommerfelt H., Strand T.A., Kapoor V., Saini S., et al. ORS containing zinc does not reduce duration or stool volume of acute diarrhea in hospitalized children. J Pediatr Gastroenterol Nutr 2011, 53:161-167.
59. Negi R., Dewan P., Shah D., Das S., Bhatnagar S., Gupta P. Oral zinc supplements are ineffective for treating acute dehydrating diarrhoea in 5-12-year-olds. Acta Paediatr 2015, 104:e367-e371.